Chronic Myeloid Leukemia

Featured

Podcast
Real-World Treatment Patterns, HCRU in Patients With CML Achieving Later Lines of Therapy
Ehab Atallah, MD, discusses results from a study evaluating treatment patterns in patients with CML achieving later lines of therapy, and estimating the associated HCRU and costs.
Conference Coverage
Real-World Treatment Patterns, Health Care Resource Utilization, and Costs in CML
For patients with CML, switching to the subsequent lines of therapy is frequent due to previous TKI intolerance and…
Podcast
Economic Burden of CML Treatment in the US: Before and After the Availability of Generic Imatinib
Gary Lyman, MD, Fred Hutchinson Cancer Research Center, discusses a project exploring the cost of TKIs, particularly…
Research Report
Trend in TKI Use, Adherence, and Switching Patterns in Patients With CML: Before and After the Availability of Generic Imatinib
Henry J Henk, PhD, and colleagues examined 10-year US trends in TKI treatment selection, switching, adherence, and…
News
Cost-Effectiveness of Therapeutic Drug Monitoring in CML
The cost-effectiveness of therapeutic drug monitoring for imatinib administration in CML may fall within an acceptable…

News

Cost-Effectiveness of Therapeutic Drug Monitoring in CML
CML Patient Views on Psychological Support During Treatment-Free Remission
Health Care Costs of CML Therapy vs Other Hematologic Malignancies
Second-Generation TKI Reimbursement for Patients With Chronic-Phase CML

Interviews

Treatment-Free Remission Test Offers "Paradigm-Shifting" Value in CML

Podcast

Real-World Treatment Patterns, HCRU in Patients With CML Achieving Later Lines of Therapy